Company news
Coegin Pharma Ab (NGM:COEGIN) news
Coegin Pharma Ab news releases on 6ix. Latest, May 21, 2026: COEGIN: First commercial revenues achieved, portfolio expanded, and liquidity strengthened via…
Press releases & updates
COEGIN: First commercial revenues achieved, portfolio expanded, and liquidity strengthened via share issue
May 21, 2026
COEGIN: First commercial revenues achieved and liquidity strengthened, with expansion planned for 2026
February 26, 2026
COEGIN: Shifted to commercial operations with first Follicopeptide orders and improved financials
November 20, 2025
COEGIN: On track for hair growth product launch, costs cut 80%, and cash runway secured into Q2 2026
August 21, 2025
COEGIN: Follicopeptide launch on track, with improved Q1 results and strong market positioning
May 22, 2025
COEGIN: Strong R&D progress and partnerships, but future funding remains a key uncertainty
February 27, 2025
COEGIN: Follicopeptide targets a Q4 2025 launch in Europe and the U.S., with strong clinical results and partner support
December 18, 2024
COEGIN: Major milestones and financing position Coegin Pharma for product launches in 2025–2026
November 19, 2024
COEGIN: FOL005 launch preparations and new partnerships drive progress amid improved financials
August 22, 2024